Skip to main content

Knowledge Zone

Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of the 12th of August, we are planning to work on 19 projects, including:

Reimbursement

  1. Working on the reimbursement analysis for an MRI technology in Germany
  2. Finalizing the reimbursement analysis for a number of in-vitro diagnostic tests in the obstetrics and gynecology field in Belgium, Bulgaria, the Czech Republic, France, Germany, Italy, Norway, Romania, and Switzerland
  3. Finalizing the reimbursement analysis for a neurostimulator in the cardiology field in England, France, Germany and Italy
  4. Finalizing the work on coding guides for physicians for technology in the cardiology field in England, Germany and Switzerland
  5. Working on reimbursement analysis and strategy for in-vitro diagnostic test in the diabetes field in Belgium and Italy
  6. Finalizing high-level recommendations for medical technology in the ICU settings in Austria, Belgium, England, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden and Switzerland
  7. Working on reimbursement analysis project for four cardiology and peripheral vascular technologies in Italy and Poland
  8. Working on reimbursement analysis for medical technology in the cardiology field in Belgium, the Czech Republic, Denmark, Finland, Luxembourg, the Netherlands, Norway, and Sweden
  9. Starting a policy analysis project, including qualitative interviews in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
  10. Developing an overview of payment mechanisms for hospital procedures and devices in Belgium, Denmark, England, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, and Switzerland
  11. Finalizing the reimbursement strategy project for imaging technology in cardiology space in Austria, Belgium, England, France, Germany, Italy, and the Netherlands
  12. Initiating the reimbursement analysis for cardiac monitoring solutions in Finland

HEOR

  1. Working on adaptations of the health economic model for in-vitro diagnostic test in infectious diseases area in France and Spain
  2. Working on the development of the health economic model for technology in the breast cancer space in the UK
  3. Implementing feedback from the client on the policy paper for diabetes technology
  4. Working on the development of the health economic model for a technology to treat venous disease in Germany
  5. Working on the development of a European value dossier for a wound care product
  6. Working on Evidence Gap Analysis for imaging technology in cardiology space in Austria, Belgium, England, France, Italy, and the Netherlands
  7. Working on the development of a value dossier for a urinary technology in EMEA region

Let us know if you need any market access or HEOR support for your medical technology in Europe.